Jennifer Dwyer, M.D.
NPI 1033524640 · Urology Physician · Omaha, NE
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1033524640
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- 7254 (NE)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
11 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,533 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 499 | $117 |
| Ultrasound Measurement of Bladder Capacity After Voiding51798 | 388 | $10 |
| Automated Urinalysis Test81003 | 308 | $2 |
| Manual Urinalysis Test With Examination Using Microscope, Automated81001 | 225 | $3 |
| Diagnostic Exam of Bladder and Urethra Using an Endoscope52000 | 141 | $71 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 121 | $9 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 18 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 126 | 41 |
| Mirabegronbrand: Myrbetriq | 114 | 32 |
| Estradiol | 93 | 59 |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 90 | 53 |
| Vibegronbrand: Gemtesa | 78 | 24 |
| Finasteride | 67 | 23 |
| Oxybutynin Chloridebrand: Oxybutynin Chloride Er |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$62 across 4 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2014-06-23
- Last updated
- 2015-07-25
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.